IL17RD and breast carcinoma: IL17RD was also shown to interact with the elements of the canonical Wingless and Int (WNT) pathway, specifically β-catenin (CTNNB1) to modulate the metastatic and tumorigenic phenotype of breast cancer cells in vitro and in vivo [44].